Teleflex Incorporated (NYSE:TFX) – Analysts at Jefferies Group decreased their Q4 2017 earnings per share estimates for Teleflex in a research report issued on Friday. Jefferies Group analyst R. Denhoy now forecasts that the medical technology company will post earnings per share of $2.35 for the quarter, down from their prior forecast of $2.39. Jefferies Group currently has a “Buy” rating and a $270.00 target price on the stock. Jefferies Group also issued estimates for Teleflex’s Q1 2018 earnings at $2.14 EPS, Q3 2018 earnings at $2.46 EPS, FY2018 earnings at $9.70 EPS, FY2019 earnings at $11.25 EPS and FY2020 earnings at $12.47 EPS.

Teleflex (NYSE:TFX) last released its earnings results on Thursday, August 3rd. The medical technology company reported $2.04 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.91 by $0.13. Teleflex had a return on equity of 16.12% and a net margin of 12.36%. The business had revenue of $528.60 million during the quarter, compared to the consensus estimate of $518.98 million. During the same period last year, the business posted $1.89 earnings per share. The business’s revenue for the quarter was up 11.6% on a year-over-year basis.

COPYRIGHT VIOLATION NOTICE: “Equities Analysts Issue Forecasts for Teleflex Incorporated’s Q4 2017 Earnings (TFX)” was reported by American Banking News and is owned by of American Banking News. If you are viewing this piece on another website, it was stolen and reposted in violation of US and international copyright laws. The correct version of this piece can be accessed at https://www.americanbankingnews.com/2017/09/11/equities-analysts-issue-forecasts-for-teleflex-incorporateds-q4-2017-earnings-tfx.html.

TFX has been the topic of several other reports. Zacks Investment Research cut Teleflex from a “buy” rating to a “hold” rating in a report on Thursday, August 31st. Barclays PLC reissued a “buy” rating on shares of Teleflex in a report on Monday, June 26th. Leerink Swann raised Teleflex from a “market perform” rating to an “outperform” rating and increased their price target for the company from $227.00 to $266.00 in a report on Thursday. Deutsche Bank AG reissued a “buy” rating and set a $238.00 price target (up from $220.00) on shares of Teleflex in a report on Wednesday, August 9th. Finally, BidaskClub cut Teleflex from a “hold” rating to a “sell” rating in a report on Tuesday, August 8th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have issued a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average target price of $246.00.

Shares of Teleflex (NYSE TFX) opened at 232.75 on Monday. The stock has a market capitalization of $10.48 billion, a P/E ratio of 44.51 and a beta of 1.05. Teleflex has a 52-week low of $136.53 and a 52-week high of $235.18. The firm has a 50-day moving average price of $211.66 and a 200-day moving average price of $202.56.

A number of hedge funds have recently modified their holdings of the business. Neuberger Berman Group LLC increased its stake in Teleflex by 0.5% in the 2nd quarter. Neuberger Berman Group LLC now owns 5,708 shares of the medical technology company’s stock worth $1,186,000 after buying an additional 28 shares in the last quarter. Stifel Financial Corp increased its stake in Teleflex by 0.6% in the 2nd quarter. Stifel Financial Corp now owns 5,399 shares of the medical technology company’s stock worth $1,121,000 after buying an additional 31 shares in the last quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. increased its stake in Teleflex by 0.6% in the 1st quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 6,553 shares of the medical technology company’s stock worth $1,270,000 after buying an additional 37 shares in the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its stake in Teleflex by 0.6% in the 1st quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 6,560 shares of the medical technology company’s stock worth $1,271,000 after buying an additional 38 shares in the last quarter. Finally, Toronto Dominion Bank increased its stake in Teleflex by 14.5% in the 2nd quarter. Toronto Dominion Bank now owns 552 shares of the medical technology company’s stock worth $115,000 after buying an additional 70 shares in the last quarter. Institutional investors and hedge funds own 90.50% of the company’s stock.

In other Teleflex news, Director Gretchen R. Haggerty purchased 1,000 shares of the business’s stock in a transaction on Wednesday, June 21st. The stock was acquired at an average price of $203.82 per share, for a total transaction of $203,820.00. Following the purchase, the director now owns 1,760 shares of the company’s stock, valued at approximately $358,723.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Stephen K. M.D. Klasko sold 200 shares of the stock in a transaction on Friday, September 1st. The stock was sold at an average price of $211.75, for a total value of $42,350.00. Following the completion of the sale, the director now owns 8,080 shares of the company’s stock, valued at approximately $1,710,940. The disclosure for this sale can be found here. Insiders sold a total of 600 shares of company stock valued at $125,652 in the last quarter. 2.39% of the stock is currently owned by company insiders.

The firm also recently declared a quarterly dividend, which will be paid on Friday, September 15th. Shareholders of record on Tuesday, August 15th will be paid a $0.34 dividend. The ex-dividend date is Friday, August 11th. This represents a $1.36 dividend on an annualized basis and a yield of 0.58%. Teleflex’s payout ratio is presently 26.00%.

About Teleflex

Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).

Earnings History and Estimates for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.